Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Genmab A/S
13G
GMAB · 372303206
|
5.9% |
10/5/2026
Event 9/28/2026
|
|||
| Darwin Global Management, Ltd. | 5.9% | ||||
| Dr. Abhishek Trehan | 5.9% | ||||
| Darwin Global Master Fund, Ltd. | 5.7% | ||||
|
INSMED Inc
13G/A
Amendment 5
INSM · 457669307
|
3.0% |
8/14/2026
Event 6/30/2026
|
|||
| Darwin Global Management, Ltd. | 3.0% | ||||
| Dr. Abhishek Trehan | 3.0% | ||||
| Darwin Global Master Fund, Ltd. | 2.9% | ||||
|
INSMED Inc
13G/A
Amendment 4
INSM · 457669307
|
7.8% |
5/15/2026
Event 3/31/2026
|
|||
| Darwin Global Management, Ltd. | 7.8% | ||||
| Dr. Abhishek Trehan | 7.8% | ||||
| Darwin Global Master Fund, Ltd. | 6.6% | ||||
|
Belite Bio, Inc
13G/A
Amendment 1
BLTE · 07782B104
|
8.1% |
2/17/2026
Event 12/31/2025
|
|||
| Darwin Global Management, Ltd. | 8.1% | ||||
| Trehan Abhishek | 8.1% | ||||
| Darwin Global Master Fund, Ltd. | 7.8% | ||||
|
Belite Bio, Inc
13G
BLTE · 07782B104
|
7.0% |
12/10/2025
Event 12/3/2025
|
|||
| Darwin Global Management, Ltd. | 7.0% | ||||
| Dr. Abhishek Trehan | 7.0% | ||||
| Darwin Global Master Fund, Ltd. | 6.7% | ||||
|
INSMED Inc
13G/A
Amendment 3
INSM · 457669307
|
9.7% |
11/14/2025
Event 9/30/2025
|
|||
| Darwin Global Management, Ltd. | 9.7% | ||||
| Dr. Abhishek Trehan | 9.7% | ||||
| Darwin Global Master Fund, Ltd. | 9.5% | ||||
|
INSMED Inc
13G/A
Amendment 2
INSM · 457669307
|
8.5% |
5/15/2025
Event 3/31/2025
|
|||
| Darwin Global Management, Ltd. | 8.5% | ||||
| Dr. Abhishek Trehan | 8.5% | ||||
| Darwin Global Master Fund, Ltd. | 7.5% | ||||
|
INSMED Inc
13G/A
Amendment 1
INSM · 457669307
|
7.2% |
2/14/2025
Event 12/31/2024
|
|||
| Darwin Global Management, Ltd. | 7.2% | ||||
| Dr. Abhishek Trehan | 7.2% | ||||
| Darwin Global Master Fund, Ltd. | 6.4% | ||||